Eton has acquired the rights in the US to Amglidia for neonatal diabetes mellitus, from French biotechnology company AMMTeK.

Insulin resistance, or low insulin sensitivity, happens when cells throughout the body don’t respond properly to the hormone ...

One of the biggest obstacles to Ozempic accessibility is cost. If you’re paying for the GLP-1 drug out of pocket, the list ...

Metformin and GLP-1 receptor agonists significantly reduce asthma attacks in patients with type 2 diabetes, offering ...

Hyundai Motor America announced a $50,000 donation to UCI Health to bolster its diabetes support services at the UCI Health ...

While diabetes gets a lot of attention, people with Type 1 Diabetes (T1D) are frequently overlooked when drug companies develop new medications. "People with T1D and chronic kidney disease, or CKD, ...

The "Type 2 Diabetes - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about 75+ companies and 80+ pipeline drugs ...

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...

Amglidia® has been approved by the European Medicines Agency (EMA) and is commercially available in EuropeStrong strategic ...

The "Diabetes - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering. This "Diabetes - Pipeline Insight, 2024" report provides comprehensive insights about 200+ ...

A recent groundbreaking study found that Glucagon-like peptide 1 receptor agonists (GLP1-RA) are effective in reducing venous ...

November is Diabetes Awareness Month, with November 14th designated as World Diabetes Day to highlight the growing prevalence ...